In the BioHarmony Drug Report Database
Deucravacitinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against non-receptor tyrosine-protein kinase TYK2. In addition, it is known to target tyrosine-protein kinase JAK1 and bone morphogenetic protein receptor type-2.
Image (chem structure or protein)